IRIS
ULIVELLI, MONICA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.217
EU - Europa 6.976
AS - Asia 3.142
SA - Sud America 639
AF - Africa 101
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 10
Totale 19.101
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.103
GB - Regno Unito 1.976
RU - Federazione Russa 1.349
CN - Cina 1.168
SG - Singapore 1.036
IE - Irlanda 922
IT - Italia 805
BR - Brasile 548
SE - Svezia 514
UA - Ucraina 446
DE - Germania 305
FR - Francia 284
HK - Hong Kong 266
KR - Corea 181
VN - Vietnam 165
FI - Finlandia 157
TR - Turchia 80
IN - India 72
CA - Canada 56
ES - Italia 45
CI - Costa d'Avorio 44
MX - Messico 38
AR - Argentina 32
NL - Olanda 31
PL - Polonia 31
AT - Austria 30
BD - Bangladesh 23
BE - Belgio 23
IQ - Iraq 23
ZA - Sudafrica 19
SA - Arabia Saudita 17
JP - Giappone 16
AU - Australia 14
EC - Ecuador 14
PK - Pakistan 14
VE - Venezuela 12
AE - Emirati Arabi Uniti 9
CL - Cile 9
ID - Indonesia 9
MA - Marocco 9
CO - Colombia 8
CZ - Repubblica Ceca 8
KZ - Kazakistan 8
EU - Europa 7
GR - Grecia 7
IL - Israele 7
PE - Perù 7
JO - Giordania 6
LT - Lituania 6
NP - Nepal 6
UZ - Uzbekistan 6
DZ - Algeria 5
JM - Giamaica 5
MN - Mongolia 5
PY - Paraguay 5
RO - Romania 5
AL - Albania 4
EG - Egitto 4
IR - Iran 4
KE - Kenya 4
LV - Lettonia 4
OM - Oman 4
SN - Senegal 4
TN - Tunisia 4
CR - Costa Rica 3
DK - Danimarca 3
EE - Estonia 3
KG - Kirghizistan 3
LB - Libano 3
LK - Sri Lanka 3
LU - Lussemburgo 3
MY - Malesia 3
PA - Panama 3
RS - Serbia 3
BG - Bulgaria 2
BO - Bolivia 2
DO - Repubblica Dominicana 2
GT - Guatemala 2
NG - Nigeria 2
NO - Norvegia 2
PH - Filippine 2
SI - Slovenia 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BW - Botswana 1
CH - Svizzera 1
CU - Cuba 1
CY - Cipro 1
GA - Gabon 1
GE - Georgia 1
HU - Ungheria 1
IM - Isola di Man 1
MD - Moldavia 1
MG - Madagascar 1
ML - Mali 1
Totale 19.094
Salva come PNG Salva come JPEG
Città #
Southend 1.830
Fairfield 976
Dublin 911
Dallas 897
Ashburn 629
Singapore 545
Chandler 522
Woodbridge 452
Santa Clara 446
Wilmington 393
Moscow 366
Jacksonville 365
Houston 343
Cambridge 340
Seattle 338
Beijing 319
Hong Kong 257
Ann Arbor 243
Siena 202
Hefei 189
Seoul 181
Princeton 159
Menlo Park 138
Nanjing 115
Los Angeles 98
Milan 92
The Dalles 89
Helsinki 69
Dong Ket 61
Munich 61
Boardman 60
Florence 60
San Diego 60
New York 59
San Mateo 55
São Paulo 52
Buffalo 50
Dearborn 50
Abidjan 44
Nanchang 44
Ho Chi Minh City 43
Izmir 41
Shanghai 40
Columbus 37
Norwalk 37
Council Bluffs 36
London 35
Tianjin 34
Rome 33
Málaga 31
Redondo Beach 31
Shenyang 27
Bengaluru 25
Warsaw 25
Brussels 23
Jinan 23
San Francisco 23
Nuremberg 22
Hanoi 21
Triggiano 20
Changsha 19
Rio de Janeiro 19
Vienna 19
Belo Horizonte 18
Fremont 18
Mexico City 18
Chicago 17
Guangzhou 17
San Jose 17
Turku 17
Denver 16
Düsseldorf 16
Johannesburg 16
Kunming 15
Stockholm 15
Boston 14
Lappeenranta 14
Ottawa 14
Tokyo 14
Ankara 13
Brooklyn 13
Toronto 13
Zhengzhou 13
Jiaxing 12
Orem 12
Washington 12
Hebei 11
Prato 11
Amsterdam 10
Chennai 10
Hangzhou 10
Kilburn 10
North Bergen 10
Phoenix 10
Campinas 9
Cisano Bergamasco 9
Frankfurt am Main 9
Montreal 9
Salvador 9
Atlanta 8
Totale 13.303
Salva come PNG Salva come JPEG
Nome #
Incidenza della sclerosi multipla in Toscana: uno studio basato su dati amministrativi 353
A mimic of first dorsal interosseus atrophy revealed by ultrasound study 300
Which patients discontinue? Issues on Levodopa/carbidopa intestinal gel treatment: Italian multicentre survey of 905 patients with long-term follow-up 300
Relevance of cognitive deterioration in early relapsing-remitting MS: a 3-year follow-up study 283
Multiple sclerosis incidence in Tuscany from administrative data 278
Cross-Modal Audiovisual Modulation of Corticospinal Motor Synergies in Professional Piano Players: A TMS Study during Motor Imagery 276
Multiple sclerosis spatial cluster in Tuscany 258
Homocysteinemia control by cysteine in cerebral vascular patients after methionine loading test: evidences in physiological and pathological conditions in cerebro-vascular and multiple sclerosis patients 257
Multiple sclerosis incidence in Tuscany from administrative data 248
A clinically silent, but severe, duodenal complication of duodopa infusion 238
Individual factors enhance poor health-related quality of life outcome in multiple sclerosis patients. Significance of predictive determinants 238
Dysfunctions of cortical excitability in drug-naïve posttraumatic stress disorder patients 236
Prevalence of multiple sclerosis in tuscany (central Italy): a study based on validated administrative data 233
Relevance of 4-F4t-neuroprostane and 10-F4t-neuroprostane to neurological diseases 230
Polysomnographic characterization of pergolide-induced sleep attacks in idiopathic PD. 229
Incidenza della sclerosi multipla in Toscana: uno studio basato sui dati amministrativi 229
Reliability, practice effects, and change indices for Rao's Brief Repeatable Battery. 228
Increasing prevalence of multiple sclerosis in Tuscany, Italy 228
Citalopram as treatment of depression in patients with epilepsy 225
Complessità terapeutico-assistenziale e management della sclerosi multipla: utilizzo di indicatori basati sul dato amministrativo 220
Non-motor symptoms in atypical and secondary parkinsonism: the PRIAMO study. 219
The Italian Multiple Sclerosis Register 219
The control of hyperhomocysteinemia through thiol exchange mechanisms by mesna 217
Anhedonia and cognitive impairment in Parkinson's disease: Italian validation of the Snaith-Hamilton Pleasure Scale and its application in the clinical routine practice during the PRIAMO study 216
COVID-19 Severity in Multiple Sclerosis: Putting Data Into Context 213
Mortality trend for multiple sclerosis in Italy during the period 1980–2015 212
Antiparkinsonian drugs and visual hallucinations 211
Carbamazepine and carbamazepine-epoxide plasma levels during lamotrigine add-on [Livelli plasmatici di carbamazepina e carbamazepina epossido dopo add-on di lamotrigina] 210
CAT and MRI in the study of partial epilepsy: comparison of the 2 methods and correlations with EEG [TAC e RMN nello studio delle epilessie parziali: confronto tra le due metodiche e correlazioni con l'EEG] 210
Hypofunctioning of sensory gating mechanisms in patients with obsessive-compulsive disorder. 209
Prevalence of multiple sclerosis in Tuscany at 2011: a study based on validated administrative data 209
Clinical evidence of fluconazole-induced carbamazepine toxicity 208
A real electro-magnetic placebo (REMP) device for sham transcranial magnetic stimulation (TMS) 208
Neurophysiological Correlates of Central Fatigue in Healthy Subjects and Multiple Sclerosis Patients before and after Treatment with Amantadine 207
The influence of diabetes and hyperglycemia on clinical course after intracerebral hemorrhage. 207
Incidenza della sclerosi multipla in Toscana: uno studio basato su dati amministrativi 206
Breakthrough SARS-CoV-2 infections in MS patients on disease-modifying therapies 201
Jitter of corticospinal neurons during repetitive transcranial magnetic stimulation. Method and possible clinical implications 200
Association of celiac disease in patients with multiple sclerosis in Tuscany 197
Distinct olfactory cross-modal effects on the human motor system 192
Increasing prevalence of multiple sclerosis in Tuscany: a study based on validated administrative data 191
Somatosensory evoked potentials reflect the upper limb motor performance in multiple sclerosis. 191
Effects of repetitive transcranial magnetic stimulation on movement-related cortical activity in humans 190
La distribuzione geografica della sclerosi multipla in Toscana 189
Effects of repetitive transcranial magnetic stimulation on chronic tinnitus: a randomised, crossover, double blind, placebo controlled study 188
Detection of disability worsening in relapsing-remitting multiple sclerosis patients: a real-world roving Expanded Disability Status Scale reference analysis from the Italian Multiple Sclerosis Register 182
Emerging of new bioartificial corticospinal motor synergies using a robotic additional thumb 182
Early somatosensory processing during tonic muscle pain in humans: relation to loss of proprioception and motor 'defensive' strategies 181
Antibody response elicited by the SARS-CoV-2 vaccine booster in patients with multiple sclerosis: Who gains from it? 180
Observational case-control study of the prevalence of chronic cerebrospinal venous insufficiency in multiple sclerosis: results from the CoSMo study 180
Reliability of administrative data for the identification of Parkinson's disease cohorts 179
Prevalence of multiple sclerosis in Tuscany: a study based on administrative data 176
Repetitive transcranial magnetic stimulation (rTMS) in the treatment of obsessive-compulsive disorder (OCD) and Tourette's syndrome (TS) 176
The olfactory side of Parkinson disease: Relevance for clinical practice 175
Wearable haptic anklets for gait and freezing improvement in Parkinson’s disease: a proof-of-concept study 175
Increasing prevalence of multiple sclerosis in Tuscany: a study based on validated administrative data 174
Safety of the first dose of fingolimod for multiple sclerosis: Results of an open-label clinical trial 174
Breakthrough SARS-CoV-2 infections after COVID-19 mRNA vaccination in MS patients on disease modifying therapies during the Delta and the Omicron waves in Italy 172
Imaging of the dopamine transporter predicts pattern of disease progression and response to levodopa in patients with schizophrenia and parkinsonism: a 2-year follow-up multicenter study 172
The heart side of brain neuromodulation 172
Clinical and MRI measures to identify non-acute MOG-antibody disease in adults 171
Reply to "Motor assessment of upper extremity function and its relation with fatigue, cognitive function and quality of life in multiple sclerosis patients" 170
Repetitive Transcranial Magnetic Stimulation (rTMS) in the treatment of panic disorder (PD) with comorbid major depression 170
Multicenter case-control study on restless legs syndrome in multiple sclerosis: the REMS study 170
Primary intraventricular haemorrhage in adults 169
Feasibility of TMS in patients with new generation cochlear implants 168
Effects of immunotherapy on motor cortex excitability in Stiff Person Syndrome 167
Human herpesvirus-6B active infection associated with relapsing bilateral anterior optic neuritis 167
Seizures after spontaneous supratentorial intracerebral hemorrhage 166
The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease 166
Effects of rehabilitation treatment of the upper limb in multiple sclerosis patients and predictive value of neurophysiological measures 165
Somatosensory processing during movement observation in humans 164
Regulation of redox forms of plasma thiols by albumin in multiple sclerosis after fasting and methionine loading test 164
Mortality of Parkinson’s disease in Italy from 1980 to 2015 164
Suprathreshold 0.3 Hz repetitive TMS prolongs the cortical silent period: potential implications for therapeutic trials in epilepsy 161
Modulation of high-frequency (600 Hz) somatosensory-evoked potentials after rTMS of the primary sensory cortex 160
Access to social security benefits among multiple sclerosis patients in Italy: A cross-sectional study 157
The PRIAMO study: age- and sex-related relationship between prodromal constipation and disease phenotype in early Parkinson’s disease 156
Temporal dynamics of memory trace formation in the human prefrontal cortex 155
Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapies 154
Slow repetitive TMS for drug-resistant epilepsy: clinical and EEG findings of a placebo-controlled trial 151
Frequency of the LRRK2 G2019S mutation in Italian patients affected by Parkinson's disease 149
Quantitative ColourDopplerSonography evaluation of cerebral venous outflow: a comparative study between patients with multiple sclerosis and controls 148
rTMS for PTSD: induced merciful oblivion or elimination of abnormal hypermnesia? 146
SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study 141
Reduction of cortical myoclonus-related epileptic activity following slow-frequency rTMS 138
DMTs and Covid-19 severity in MS: a pooled analysis from Italy and France 136
Mortality of Alzheimer’s disease in Italy from 1980 to 2015 131
Quantitative analysis of Lamotrigine in plasma and tablets by planar chromatography and comparison with liquid 130
Human ventral parietal cortex plays a functional role on visuospatial attention and primary consciousness. A repetitive transcranial magnetic stimulation study 122
Prospective study of clinical, neurophysiological and urodynamic findings in multiple scleosis patients undergoing percutaneous transluminal venous angioplasty 122
Prevalence and impact of COVID-19 in Parkinson’s disease: evidence from a multi-center survey in Tuscany region 118
null 112
Signs and symptoms of Covid‐19 in patients with multiple sclerosis 107
null 106
The role of ethnicity and native-country income in multiple sclerosis: the Italian multicentre study (MS-MigIT) 104
The effect of air pollution on COVID-19 severity in a sample of patients with multiple sclerosis 104
Does Risk of Hyperhomocysteinemia Depend on Thiol-Disulfide Exchange Reactions of Albumin and Homocysteine? 103
Pisa syndrome in Parkinson disease 103
Uveitis: A snapshot in the MOG antibody spectrum 102
Totale 18.614
Salva come PNG Salva come JPEG
Categoria #
all - tutte 60.738
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 60.738
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.446 0 0 0 0 0 228 173 289 227 170 181 178
2021/20221.480 97 179 106 89 141 70 78 52 100 143 152 273
2022/20231.943 114 191 280 250 163 369 52 177 192 48 70 37
2023/20241.408 64 27 116 82 42 362 485 55 13 21 43 98
2024/20253.083 57 163 271 174 399 182 148 196 282 122 333 756
2025/20264.424 505 940 772 770 1.226 211 0 0 0 0 0 0
Totale 19.398